logo
Plus   Neg
Share
Email

Myriad Genetics Reports Regulatory Approval Of BRACAnalysis In Japan

Myriad Genetics, Inc. (MYGN) announced the Japan's Ministry of Health, Labour and Welfare has approved the BRACAnalysis Diagnostic System for Hereditary Breast and Ovarian Cancer risk assessment in patients with breast cancer.

BRACAnalysis is a genetic test that identifies germline mutations in the BRCA1/2 genes. This test will assist physicians in determining which women with breast cancer have Hereditary Breast and Ovarian Cancer syndrome and qualify for additional medical management.

Myriad has an exclusive partnership with SRL Inc. to commercialize the BRACAnalysis Diagnostic System in Japan.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Epic Games Inc., the developer of popular game Fortnite, has filed lawsuits against both Apple Inc. and Google after they removed the game from their app stores. The development reflects disputes related to app store fee the tech giants take from each purchase. Epic Games, which has been against the 30 percent revenue cut the two tech giants take from paid apps, added a direct payment option. Kader Exports pvt. Ltd. is recalling certain consignments of various frozen cooked shrimp citing potential contamination with Salmonella, according to the U.S. Food and Drug Administration. The affected frozen cooked, peeled and deveined shrimp products were sold in 1lb, 1.5lb., and 2lb. retail bags. They were distributed from late February 2020 to Mid-May 2020 across the nation. The former chief executive officer of Hertz Global Holdings, Mark Frissora, agreed to pay about $2.2 million to settle the U.S. Securities and Exchange Commission's claims that he played a key role in causing the now-bankrupt car-rental company to file inaccurate financial statements in 2013.
Follow RTT